Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme

7680677360015 CH-67736 Vaginaltabletten
Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
1 / 3
google

Article details

Package size
1
Selling units
unbekannt
Measure
Kombipackung(en)
Galenic form
Vaginaltabletten
Galenic group
Vaginal-Produkte

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/06/2022
Patient information leaflet
Français
21/06/2022
Patient information leaflet
Italien
21/06/2022
Summary of Product Characteristics
Allemand
21/06/2022
Summary of Product Characteristics
Français
21/06/2022
Summary of Product Characteristics
Italien
21/06/2022

Detailed composition

Substance Quantity Type Category
II
20.0 MG Substance Wirkstoff (Principe actif)
I
200.0 MG Substance Wirkstoff (Principe actif)
II
10.0 MG Substance HBESI
I
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
II
100.0 MG Substance HBESI
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HNIDK

Authorization holder

Max Zeller Söhne AG

8590 Romanshorn

Authorization information

Swissmedic authorization number
67736
Drug name
Kadefemin Mycostop, Vaginaltabletten und Creme
Galenic form
KOMB
ATC Code
G01AF02
Authorization status
Z
Dispensing category
D
First authorization
20/07/2021
Authorization expiration date
19/07/2026
IT Number
09.03.0.
Domain
Human medicine
Field of application
Durch Clotrimazol-empfindliche Erreger verursachte vulvovaginale Infektionen

Package details

Description (FR)
KADEFEMINE Mycostop emb combi 3 cpr vag+20 g crème
Description (DE)
KADEFEMIN Mycostop Kombipack 3 Vag Tabl+20 g Creme
Market launch
20/07/2021
Market withdrawal
01/09/2025
Narcotic (BTM)
No